The immunoregulatory landscape of human tuberculosis granulomas.
McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB, Gupta S, Greenwald NF, Baranski A, Graf W, Kumar R, Bosse M, Fullaway CC, Ramdial PK, Forgó E, Jojic V, Van Valen D, Mehra S, Khader SA, Bendall SC, van de Rijn M, Kalman D, Kaushal D, Hunter RL, Banaei N, Steyn AJC, Khatri P, Angelo M. · 2022
Read The immunoregulatory landscape of human tuberculosis granulomas. by McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB, Gupta S, Greenwald NF, Baranski A, Graf W, Kumar R, Bosse M, Fullaway CC, Ramdial PK, Forgó E, Jojic V, Van Valen D, Mehra S, Khader SA, Bendall SC, van de Rijn M, Kalman D, Kaushal D, Hunter RL, Banaei N, Steyn AJC, Khatri P, Angelo M. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8810384.txt.
Introduction
McCaffrey and co-authors map the immune landscape of human tuberculosis granulomas, the cell clusters that form in infected tissue. Their makeup is thought to shape disease outcome. Spatial links inside them were poorly known. The team imaged 37 proteins in tissue from patients with active disease.
The atlas names 19 cell subsets across 8 spatial zones. One zone lacked a key defense signal and held suppressor cells instead. Blood data from patients echoed the same regulatory trends. One checkpoint protein linked to progression to active disease and to treatment response. The data show local immune programs with body-wide signs. They may help predict who worsens.
Catalog record
| CREATOR | McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB, Gupta S, Greenwald NF, Baranski A, Graf W, Kumar R, Bosse M, Fullaway CC, Ramdial PK, Forgó E, Jojic V, Van Valen D, Mehra S, Khader SA, Bendall SC, van de Rijn M, Kalman D, Kaushal D, Hunter RL, Banaei N, Steyn AJC, Khatri P, Angelo M. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The immunoregulatory landscape of human tuberculosis granulomas By Erin F. McCaffrey, Michele Donato, Leeat Keren, Zhenghao Chen, Alea Delmastro, Megan B. Fitzpatrick, Sanjana Gupta, Noah F. Greenwald, Alex Baranski, William Graf, Rashmi Kumar, Marc Bosse Published in: Nature Immunology DOI: 10.1038/s41590-021-01121-x ABSTRACT Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However, our understanding of the spatial relationships that control human granulomas is limited. Here, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) to image 37 proteins in tissues from patients with active TB. We constructed a comprehensive atlas that maps 19 cell subsets across 8 spatial microenvironments. This atlas shows an IFN-γ-depleted microenvironment enriched for TGF-β, regulatory T cells and IDO1+ PD-L1+ myeloid cells. In a further transcriptomic meta-analysis of peripheral blood from patients with TB, immunoregulatory trends mirror those identified by granuloma imaging. Notably, PD-L1 expression is associated with progression to active TB and treatment response. These data indicate that in TB granulomas, there are local spatially coordinated immunoregulatory programs with systemic manifestations that define active TB. MAIN Mycobacterium tuberculosis (Mtb) infection accounts for nearly 1.5 million deaths each year1, prompting efforts to develop new host-directed therapies to treat TB disease. However, these efforts have been hindered by an incomplete understanding of how the human immune system responds to Mtb. Infection is initiated when bacteria are engulfed by phagocytic cells after being inhaled into the lungs2,3. This triggers an immune response that converges on formation of a granuloma, a dynamic and spatially organized tissue structure composed of macrophages, granulocytes, lymphocytes and fibroblasts. From the perspective of facilitating an effective host response, granulomas play contradictory roles. On one hand, consolidation of infected cells within the myeloid core limits dissemination by partitioning them away from uninvolved lung parenchyma. On the other, tolerogenic pathways upregulated within this region may limit bacterial clearance4–6. Granuloma composition can be highly variable7. Even within a single individual, infection can result in granulomas with distinct histologic features that each progress independently over time8. Controlled infections in non-human primates have revealed that a single individual can possess well over ten granulomas, and the inflammatory profile, size and bacterial ecology of these lesions differ dramatically9–11. Thus, the trajectory of each granuloma varies across a spectrum between complete bacterial clearance to uncontrolled dissemination. This discordance suggests that local host–bacterial dynamics within the tissue microenvironment (ME) play a central role in determining granuloma fate. Along these lines, a growing number of studies find that granuloma structure and immune cell function are interconnected12–15. Taken together, these findings suggest that TB progression is impacted by focal, spatially encoded regulatory mechanisms within the granuloma ME. Thus, understanding how these mechanisms promote bacterial clearance or persistence is critical for designing effective therapies. A necessary first step toward this goal is to characterize immune cell dynamics and regulatory pathways in human TB granulomas. However, many facets of TB granuloma pathology are human specific and difficult to emulate in model systems. This is compounded by the fact that, unlike other tissue pathologies, biopsy specimens are rarely obtained during a typical TB clinical workup. In this respect, TB is a member of a larger class of diseases, where the paucity of human material and lack of high-fidelity model systems have impeded development of new therapies. With this in mind, we applied a stepwise investigative framework where limited amounts of archival tissue and publicly available transcriptome data are integrated to glean new insight into human-specific pathobiology in TB. We employed MIBI-TOF16 to chart granuloma composition across eight computationally defined spatial MEs, revealing features of highly localized immune modulation in granulomas, such as IDO1- and PD-L1-expressing myeloid cells, proliferative regulatory T cells (Treg cells) and high levels of transforming growth factor β (TGF-β) alongside depletion of IFN-γ. We find that IDO1 seems to be specific to TB granulomas, whereas PD-L1 and sparsity of activated T cells are also found in another granulomatous condition, sarcoidosis. Lastly, in an orthogonal analysis of blood transcriptomes from patients with TB, we observe that similar immunoregulatory expression dynamics define systemic immunity during active TB. RESULTS Structured immune cell composition in human TB granulomas To assess granuloma composition and architecture in TB, we curated a cohort of actively infected human tissues. Archival formalin-fixed paraffin-embedded (FFPE) specimens from patients treated in the United States or South Africa were procured from Stanford Health Care and University of Texas Health Science Center or University of KwaZulu-Natal, Inkosi Albert Luthuli Central Hospital, respectively (Extended Data Table 1). The South African cohort comprised pulmonary tissues from patients undergoing therapeutic resection for advanced TB (n = 3), whereas a subset of US specimens came from postmortem autopsy lung tissues from patients with fatal TB (n = 3). Although TB disease typically manifests in the lung, infection can disseminate to extrapulmonary sites17. To characterize TB infection at an earlier stage and assess how granuloma composition varies with infection site, we included diagnostic biopsy specimens from lung (n = 2), pleural cavity (n = 3), lymph node (n = 2), vertebrae (n = 1) and endometrium (n = 1) (Fig. 1a).Fig. 1Multiplexed imaging of TB granulomas reveals structured immune cell composition.a, Conceptual overview of MIBI-TOF analysis of human TB granulomas, comparison with sarcoidosis and complementary analysis of systemic responses to TB. b, Representative images from a TB granuloma. c, Cell lineage assignments based on normalized expression of lineage markers (heatmap columns). Rows are ordered by absolute abundance shown on the bar plot (left), whereas columns are hierarchically clustered (Euclidean distance, average linkage). d, Cell identity overlaid onto the segmentation mask for a representative TB granuloma (left). Two insets (right) are shown. e, The relative abundance of immune cell types across all TB FOVs with cell types ordered by decreasing median abundance and bars ordered by specimen origin (resection, blue; postmortem, green; diagnostic biopsy, red). f, Frequency of CD14+ monocytes and 11b/c+ 206+ macrophages among total immune cells colored by specimen origin. Line represents the median. g, The CD4+ T cell/CD8+ T cell ratio represented as a log2 fold change for each TB FOV (top) colored by specimen origin (top) and frequency of CD4+ T cells (middle) and CD8+ T cells (bottom) among total immune cells. h, Frequency of CD4+ and CD8+ T cells among total immune cells colored by specimen origin. Line represents the median. i, Linear relationship between the CD4+ T cell/CD8+ T cell ratio and 11b/c+ 206+ macrophage/CD14+ monocyte ratio. Linear regression (black solid line) with 95% confidence interval (CI; black dashed line) displayed. Significance was established with a t test (two tailed). Unless specified, all other P values were calculated with a Wilcoxon rank-sum test (two tailed) (*P < 0.05; **P < 0.01; ***P < 0.001). Coll, collagen-1; mac, macrophage; mono, monocyte; MPO, myeloperoxidase; ROI, region of interest; VIM, Vimentin. Each specimen was reviewed by an anatomic pathologist and screened to include the presence of active granulomatous inflammation (Extended Data Fig. 1a). MIBI-TOF was subsequently used to image two 500 μm × 500 μm fields of view (FOVs) per tissue after staining with a 37-plex panel of metal-labeled antibodies (Fig. 1b, Extended Data Fig. 1b,c and Extended Data Table 2)